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ABSTRACT 
In the current study, corn bran was treated with hydrothermal processing and then 
incorporated into bread. The consumption of bread with inclusion of treated corn bran 
(TCB) and control bread (CB) on postprandial glycaemic response was investigated in 
a randomised crossover intervention trial with eleven healthy participants and one 
hyperglycaemicparticipant, capillary blood samples were measured at 0, 15, 30, 45, 60, 
75, 90, 105 and 120 minutes after consuming the bread.  
 
The results showed the baseline-adjusted peak value of postprandial blood glucose 
with consumption of CB, containing 75 g carbohydrate was 4.27 mmol/L at 60 min after 
meal, but with consumption of treated corn bran bread (TCBB), containing 75 g 
carbohydrate was 3.88 mmol/L at 45 min after meal. In addition, the postprandial 
blood glucose concentration with consumption of CB is consistently higher than that 
with the consumption of TCBB since the peak time to 120 min. However, there was no 
significant differences, in turn, the incremental area under the curves (IAUC) with 
baseline-adjusted for CB consumption is consistently higher than that of TCBB 
consumption, but not any significant difference either (p>0.05). However, it is 
interesting to notice that more considerable difference in rise of blood sugar at peak 
time and thereafter for hyperglycaemicparticipant between the consumptions of TCBB 
and CB.  
 
In conclusion, the consumption of bread with inclusion of TCB is able to reduce the 
postprandial glycaemic response to a lower level compared with the consumption of 
CB and the more obvious difference was observed with the hyperglycaemicparticipant 
and healthy group 
 
Key words: Corn bran, hydrothermal treatment, postprandial glycaemic response. 
Intervention trial.  
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1. Introduction 
1.1 Background 
 
Cereal bran is the by-product in cereal processing, which is rich in protein, dietary fibre 
and vitamins [1]. Non-starch polysaccharides is the main components of dietary fibre 
which corporate with protein and other components to form the cell wall materials of 
plants [2, 3]. 
 
With consumers paying more attention to dietary health, cereal products are becoming 
more and more popular. Studies have shown that cereal products promote intestinal 
digestion, reduce blood glucose, and reduce cholesterol and the risk cardiovascular 
diseases [4, 5, 6, 7]. Diabetes is a chronic hyperglycaemic metabolic syndrome caused by 
defects in insulin secretion [6, 8]. The incidence of diabetes mellitus is increasing year by 
year [5]. In 1988, Jenkins et al. [9] first proposed the concept of postprandial blood 
glucose level. Since then, many researches have been reported that a high fibre diet has 
the benefit of lowering blood sugar and improving the reduction of postprandial glucose 
level [10, 11, 12]. Even though the studies on prevention of diabetes by the consumption 
of foods with enriched fibre have been well documented [5, 7, 13, 14], it is till a challenge 
to find affordable food material for effectively reducing the post prandial glycaemic 
response for consumption of starch-riched foods.  
 
In this study, corn bran was treated through hydrothermal processing and was 
incorporated into bread.  The effects on the intake of TCBB and CB on the postprandial 
glycaemic response were investigated in a randomised cross-over intervention human 
trial. The changes in blood glucose for eleven healthy participants and one 
hyperglycaemic participant were measured and were compared. The results from this 
study were expected to provide a better understanding of the consumption of TCBB and 
CB on postprandial glycaemic response for both healthy participants and hyperglycaemic 
participant.  
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2. Method 
Experimental design  
Fig. 1 shows a flow diagram of the experimental design used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 Bread preparation 
 
2.1.1 Bread recipe 
Bread were prepared from the formulation, as showing in Table 1, the corn bran were 
processed by hydrothermal treatment. 
 
Table 1. Bread formulation. 
   CB TCBB 
Figure 1. Experimental design for the study of treated corn bran extraction improvement in corn bran and the application in 
bread and postprandial glycaemic response. 
 
Corn bran 
 Corn bran hydrothermal treatment 
Analysis: 
Postprandial glucose response 
Incremental area under the Curves (IAUC) 
 
Incorporated the processed material in to bread 
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(g) (g) 
Strong flour 600 435 
Yeast 15 15 
Salt 10 10 
Butter 30 30 
Corn bran  0 165 
Water 40°C 336 627 
Dry weight 655 655 
Total weight 991 1282 
 
2.1.2 Bread making 
Fig. 2 shows the flow chart of the bread preparation procedure. 
Dry materials+ fat + water (40°C), mixed for 12 min 
Divided into dough pieces (300g control, 320g corn bran) 
 
Rounded into dough pieces and placed produces at oven  
Fermentation at 37°C and 90% humidity for 45 min 
 
Preheated oven to 220°C 
Baked at 220°C 2 min, 210°C for 8 min, 185°C for 12 min  
 
Cooled for 12 hours at room temperature 
 
Figure 2. Bread preparation procedure.  
Dough processing 
Dough proofing 
Bread baking 
Cooling  
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2.2.  Postprandial glycaemic response intervention trial 
 
A randomised crossover intervention trail was conducted in 2018 at University of Chester 
Clinic Lab (Chester, UK).  Eleven healthy and one hyperglycaemic participants over 18 
year-old males and females were recruited in this study. The physical characteristics and 
age of participants were obtained from a questionnaire. Participants were aged between 
28 and 55, eleven healthy participants fasting glucose levels ≤6.0 mmol/L and one 
hyperglycaemic participant fasting blood glucose (FBG) level > 7.0 mmol/L, were non-
smokers, had no history of cancer or metabolic diseases and were not pregnant (if female).  
In order to determine Body Mass Index (BMI), height ruler (Seca, UK) and scale (Seca, UK) 
measured the weight and height (without footwear) of participants respectively. The BMI 
was between 19 and 31 kg/m2. The ethnicity of the participants was Chinese. For each 
experiment, the participants were asked to fasting for 12 hours (water drinking was 
allowed) prior to providing blood samples. Before attending the Clinic Lab, participants 
were asked to abstain from alcohol and vigorous exercise for 12 hours. Each participant 
was required to attend two separate occasions to consume either TCBB or CB with 75g 
available carbohydrate.  
The measurements were performed in August 2018 at the University of Chester Clinic Lab 
(Chester, UK). The research was approved by the Faculty of Medicine, Dentistry and Life 
Sciences Research Ethics Committee (FREC reference: 1459 (1429)/18/ZC/CSN, The 
University of Chester, 2018). The study followed University of Chester ethics process 
guidelines. This intervention human trial crossover test was carried out on two separate 
occasions, one week apart. Postprandial glucose was measured by a finger prick glucose 
detector device (Contour next, Parsippany, UK). Participation was voluntary, and the 
participants were reassured of their right to withdraw any time from the study without 
giving a reason. All participants were provided with both verbal and written information, 
and gave informed consent. Blood samples and research data were coded at the source 
and anonymised.  
 
7 | P a g e  
 
All participants were randomised to consume either the TCBB or the CB on two separate 
occasions. Therefore, all participants consumed either the TCBB or the CB containing75- 
g of carbohydrates. Capillary blood was obtained on each occasion from finger prick 
samples according to the standard protocol of the phlebotomy unit. Blood samples were 
obtained at 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes after consuming either the TCBB 
or CB. 
 
Nutrition profile of TCBB and CB 
Both TCBB and CB followed the bread-making recipe in Table 1. The TCBB and CB were 
matched for carbohydrate, protein and fat as shown in Table 2. The nutrition profile was 
investigated by NUTRITICS software to determine the nutrition value in both breads.  
Table 2. The nutrition value TCBB and CB. 
EU: RI (Labelling) TCBB (100g) CB (100g) 
Energy (Kcal) 219kcal 268kcal 
Energy (KJ) 928KJ 1133KJ 
Carbohydrate (g) 42g 50g 
Protein (g) 6.3g 8.5g 
Fat (g) 2.9g  3.7g 
 
2.3. Data Analysis and calculation 
 
Glycaemic Response Calculation 
Blood glucose levels were measured at 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes after 
consuming the bread, and the Incremental area under the curve (IAUC) was calculated by 
trapezoidal method. Moreover, the values that were below the FBG (baseline) value were 
excluded. See example curve in fig. 3. 
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Figure 3. Example of AUC calculation. 
Area=∑ 𝑓 (𝑥)1200 = A+B+C+D+E+F 
 
Statistical analysis 
Data analysis was performed using IBM SPSS 25 Statistical software. T-test independent 
sample were used to compare the mean value between groups. The results were 
expressed as mean± standard deviation, p <0.05 means significant difference.  
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3. Results 
 
3.1 Postprandial glycaemic response intervention trial 
 
3.1.1 Physical characteristics of participants 
Eleven healthy participants (randomised coded as N1-N11) and one hyperglycaemic 
participant (coded as N12) volunteered to participate in this research (Fig. 4), the physical 
characteristics and FBG mean value of all participants are showed in Table 3. The FBG 
concentration of eleven participants and one hyperglycaemic participant are reported in 
Table 4. 
 
 
 
 
 
 
 
 
 
 
Randomised coded  
Eleven participants (N1-N11) 
Analysis: 
 Postprandial blood glucose response 
 Incremental Area under the Curves (IAUC)  
N1, N2, N3, N4, N5 N6, N7, N8, N9, N10, N11 
One hyperglycaemicparticipant 
(N12) 
Figure 4. Scheme randomised crossover trail. 
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Table 3. Participant’s physical characteristics  
  Age (years) Weight (kg) Height (m) BMI (kg/m^2) 
  Mean± S.D. Mean± S.D. Mean± S.D. Mean± S.D. 
Participants 
Pre- diabetes  
40.82±8.48 
39 
66.48±12.63 
67 
1.63±0.08 
1.68 
25.08±3.96 
23.74 
 
 
Table 4. The mean of FBG levels of eleven participants and one hyperglycaemic participant.  
  CB TCBB 
 
Mean± S.D. Mean± S.D. 
Healthy participants FBG (mmol/L) 
Hyperglycaemic participant FBG (mmol/ L) 
5.58±0.36 
7.80 
5.56±0.34 
7.10 
 
As Table 4 shows, the high standard deviation in age and weight mean value for 
participants, resulting in the majority of BMI value in the range of 21.12 to 29.04, which 
indicated the majority of participants in the healthy weight to overweight range.   
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3.1.2 Baseline-adjusted postprandial blood glucose concentration changes 
 
 
 
 
 
Figure 5. Baseline-adjusted blood glucose concentration throughout 120 minutes following the consumption of the TCBB 
and CB (P >0.05). 
 
The changes in blood glucose concentration of participants throughout the 120 min are 
shown in Fig. 5, the FBG was considered as baseline, the increase peak value in 
postprandial blood glucose for the TCBB consumption was 45 min (3.88 mmol/L), 
however, it was for CB consumption was at 60 min (4.27 mmol/L). The baseline-adjusted 
blood glucose concentration for the consumption of TCBB was lower than that for the 
consumption of CB at all measurement points from 46 min to 120 min and the peak drop 
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rate of TCBB and CB were 0.03 for the consumption of the TCBB and 0.018 for the 
consumption of CB. However, independent t-test analysis showed that no significant 
difference in baseline-adjusted blood glucose concentration between the intake of TCBB 
and CB (p> 0.05). 
 
   
Figure 6. Changes in blood glucose concentration throughout 120 minutes following the consumption of the TCBB and CB 
for hyperglycaemicpatient.   
Fig 6 shows the baseline-adjusted blood glucose concentration for hyperglycaemic 
participant throughout 120 minutes. The blood glucose concentration peak value for the 
consumption of the TCBB was 6.1 mmol/L, however, for CB consumption, it was 
7.2mmol/L. From 75 min to 120 min, the blood glucose concentration for the 
consumption of TCBB rapidly decreased and it dropped to the similar level with those for 
healthy participants at 120min. Whilst, for the consumption of CB, the blood glucose 
concentration remained consistent level without obvious decrease. Moreover, the peak 
value of hyperglycaemic participant both with TCBB and CB were higher than that of 
healthy participants. As only one hyperglycaemic participant attended this study, the data 
is not analysed statistically.  
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With the combination of Fig 4 and Fig 5, the baseline-adjusted blood glucose peak value 
is 4.27 mmol/L and 7.2 mmol/L respectively for healthy participants and hyperglycaemic 
participant after the consumption CB. However, it is 3.88 mmol/L and 6.1 mmol/L for 
healthy range participants and hyperglycaemic participant after the consumption TCBB, 
which are lower than that of healthy participants and hyperglycaemic participant after 
the consumption CB. For the healthy participants, the postprandial blood glucose 
concentration with consumption of TCBB is consistently lower than that with CB after the 
peak time, but not statistically different. For the hyperglycaemic participant, the peak 
value of blood glucose concentration for the intake of TCBB is much more lower in 
comparison with the consumption of CB, showing a sharp decrease after the peak time, 
meanwhile no considerable decrease was observed with the consumption of CB, 
demonstrating the intake of TCBB was more effectively to reduce the blood glucose 
concentration for hyperglycaemic participant in comparison with TCBB consumption 
healthy participants.  It is interesting to notice that the increase in baseline-adjusted 
blood glucose concentration at 120 min of testing time for hyperglycaemic participant 
was at the same level as that for the healthy participants.   
 
3.1.3. Incremental Area under the Curves (IAUC) 
 
The baseline adjusted IAUC for consumption of TCBB and CB is shown in Table. 5. The 
IAUC of blood glucose concentration for consumption of TCBB is slightly lower than that 
of CB for healthy participants, but there were no significant differences (p> 0.05). For 
hyperglycaemic participant, both the intake of TCBB and CB caused a greater increase in 
blood glucose peak value and IAUC than any one for healthy participants, but more 
obvious reduction in IAUC was found with the consumption of TCBB for hyperglycaemic 
participant, showing the consumption of TCBB is able to more effectively to reduce the 
post-prandial glycaemic response for hyperglycaemic than for healthy people. 
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Table 5. Mean values of IAUC of the TCBB and CB, participant code N1-N11 are healthy participant, code N12 is 
hyperglycaemicparticipant.    
  IAUC   
Participant code CB TCBB 
N1 418 455.1 
N2 340.1 432.7 
N3 242.8 382.75 
N4 267.45 336.35 
N5 429.3 390.55 
N6 551.75 461.55 
N7 175.65 232.9 
N8 607.5 302 
N9 344.1 281.1 
N10 185 168.3 
N11 268.6 287.85 
Average ±S.D. 348.20±141.62 339.20±94.65 
N12  
  
576.6 
  
408.25 
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4. Discussion 
 
The corn bran applied in this study was treated by hydrothermal process. Many 
researchers demonstrated that the hydrothermal treatments were able to increase the 
water solubility of arabinoxylans (AXs) from cereal bran (58%- 71%) [15, 16, 17, 18].  
According to the results of current study, the change in postprandial blood glucose 
concentration at and after the peak time to the end of testing (120 min) for the healthy 
participants with consumption of TCBB is consistently lower than that with the intake of 
CB. Even though no significant difference in postprandial blood glucose concentrations 
between the consumption of TCBB and CB for healthy participants, it still demonstrates 
that the intake of TCBB has the effect on the reduction of the blood glucose rise in 
comparison with the intake of CB, which is consistent with the results from study 
conducted by Mo hlig et al. (2005) [19]. He reported that after the intake of AXs-riched 
meal, glucose response was also not significantly different in subjects with normal 
glucose regulation (p= 0.367), and the insulin responses after an AX-enriched breakfast 
showed only a tendency towards lower values (p= 0.065). His results shown that AXs-rich 
bread delayed the absorption of glucose and make the peak postprandial blood glucose 
shift more gently to later time in comparison with control white bread, but does not affect 
the total absorption of glucose. However, in the current study, no any delay in the peak 
value of glucose absorption with the intake of TCBB. The peak value of blood glucose for 
the intake of TCBB was lower than that for CB, which indicates the TCBB release less 
glucose into the blood stream in comparison with CB.  For the hyperglycaemic participant, 
the peak value for the intake of TCBB is much lower in comparison with CB, and the blood 
glucose concentration with consumption of TCBB showed more considerable decrease 
after the peak value compared with that for the intake of CB, which was almost 
maintained at same level up to 120 min. It is interesting to notice that the adjusted-
baseline postprandial glycaemic response of hyperglycaemic participant with the intake 
of TCBB dropped to the similar level to that for healthy participants at 120min. The study 
results revealed that the consumption of TCBB has more significant impact on the 
hyperglycaemic participant than on the healthy participants in terms of reducing 
postprandial glycaemic response 
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Burton et al. [20] reported that contain 50g carbohydrate were considered as ideally 
consuming meal. In 1998, the Food Agriculture Organization defined: “The glycaemic 
index is expressed as the incremental area under the blood glucose response curve of a 
50g carbohydrate portion of a test food expressed as a percent of the response to the same 
amount of carbohydrate from a standard food taken by the same subject.” In many studies, 
it  has been found that with 50g carbohydrate the peak of blood glucose response was at 
30 min [20, 21]. In the current study, the participant consumed 75 g carbohydrates either 
of TCBB or of CB in order to explore the glucose absorption with a large amount 
carbohydrate intake, which caused the blood glucose peak time shifted to 45min for TCBB 
and 60min for CB for healthy participants and 75 min for hyperglycaemic participant for 
both CB and TCBB.  
 
Vogel et al. [22] investigated functionalities of AXs gel, which extracted from corn bran by 
alkaline treatment. The results showed that the postprandial glucose response of 
intragastrically administered rats has decreased 5-9%.  As previously mentioned, the 
corn bran treated with hydrothermal process have more the water soluble AXs [15, 16, 
17, 18]. As it was incorporated into TCBB, water soluble AXs likely modulate the glucose 
release and thus reduce the postprandial glucose response for both for healthy and 
hyperglycaemic participants. 
 
For the aspects of human health and management implementations, the results of current 
study research further confiemed that AXs-riched food is able to reduce the postprandial 
glycaemic response, in turn improve glucose tolerance for healthy participants, therefore 
the AXs demonstrated a certain blood sugar regulating function for healthy people, which 
potentially contribute to less variation in blood sugar after AXs-riched meal. Furthermore, 
it is likely that AXs-enriched foods contribute to more significant reduction of 
postprandial glucose response for hyperglycaemic patients, which in turn significantly 
reduce the risk of diabetes. The European Food Safety Authority (EFSA) approved the 
consumption of wheat endosperm AXs as part of a food with no less 4.8% per 100g 
available carbohydrate contributes to a reduction of the blood glucose rise after that meal 
based on scientific review in 2011[23]. In 2018, Kellow et al. has reviewed eight 
publications, the results of eight publications show the  meal with added AXs had 
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significant utility on participant with type 2 diabetes and metabolic disturbance, but there 
was no significant difference for healthy participants, which are consistent with the 
results of current  study [24].  
5. Conclusion 
 
For health participants, the results showed that the baseline-adjusted value of 
postprandial blood glucose at and after peak time with consumption of CB is consistently 
higher than that with the consumption of TCBB, but there was no significant differences 
(p>0.05). The baseline-adjusted IAUC for consumption of CB is consistently higher than 
that for the consumption of TCBB, but not significantly either (p>0.05).  More 
considerable difference in postprandial glycaemic response from peak time to end of 
testing was noted for hyperglycaemic participant with the consumptions of TCBB and that 
of CB.  
 
The results in this study demonstrated that TCB meal (AXs-rich meal) reduced blood 
glucose response after meal and improved glucose tolerance for healthy people, showing 
blood glucose regulating function for healthy people. Furthermore, it contributed to more 
obvious reduction of blood glucose response after meal for hyperglycaemic participant. 
This research might also provide the information for hyperglycaemic control. However, 
the mechanism of treated corn bran in control of hyperglycaemic issues remains unclear 
and further research in this area should be carried out in the future. 
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